Harbour Investments’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Harbour Investments's HALO Position: Q2 2026 in Review
Harbour Investments reduced its Halozyme (HALO) stake by 22% in Q2 2026, selling an estimated $20.7K and leaving 1,048 shares worth $82.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2137.
Harbour Investments first reported a position in HALO in Q1 2021 and has held it in 10 quarters since. The position peaked at $87.4K in Q1 2026. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Harbour Investments held 1,048 shares of Halozyme worth $82.1K as of Q2 2026.
- Harbour Investments sold 304 Halozyme shares in Q2 2026, an estimated $20.7K.
- Halozyme made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #2137 holding.
- Harbour Investments first reported a position in Halozyme in Q1 2021 and has held it in 10 quarters since.
- Harbour Investments's Halozyme position peaked at $87.4K in Q1 2026.
- 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.